Patents by Inventor William G. Tatton

William G. Tatton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for increasing schwann cell survival
    Patent number: 7160857
    Abstract: Methods for increasing Schwann cell survival are disclosed. The methods of the invention are useful for the treatment of conditions such as peripheral neuropathies, including diabetic neuropathies.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: January 9, 2007
    Inventors: Nadine A. Tatton, William G. Tatton
  • Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
    Publication number: 20040180957
    Abstract: The present invention relates to the use of deprenyl compounds to rescue damaged nerve cells in a patient and to kits containing deprenyl compounds useful for rescuing damaged nerve cells in a patient.
    Type: Application
    Filed: October 14, 2003
    Publication date: September 16, 2004
    Applicant: University of Toronto
    Inventors: William G. Tatton, Carol E. Greenwood
  • Deprenyl compounds for treatment of glaucoma
    Publication number: 20040176455
    Abstract: Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
    Type: Application
    Filed: October 30, 2003
    Publication date: September 9, 2004
    Inventor: William G. Tatton
  • Treatment of dementia and parkinson's disease
    Publication number: 20040116436
    Abstract: Methods of preventing or retarding the degeneration of neurons. Also disclosed are methods for treating Alzheimer's disease or Parkinson's disease.
    Type: Application
    Filed: October 7, 2003
    Publication date: June 17, 2004
    Inventors: William G. Tatton, Larry A. Wheeler, Daniel W. Gil, John E. Donello
  • Dehydrogenase oligomeric modulators
    Publication number: 20040086891
    Abstract: Methods of screening compounds which are oligomeric modulators of dehydrogenases such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and such oligomeric modulators. In one aspect, methods are presented for identifying an oligomeric modulator of a dehydrogenase, comprising contacting the dehydrogenase with a compound under conditions which allow oligomerization of the dehydrogenase to occur; and measuring the ability of the compound to modulate oligomerization of the dehydrogenase as an indication of whether the compound is an oligomeric modulator of the dehydrogenase. In another aspect, methods are presented for identifying an oligomeric modulator of GAPDH, comprising contacting GAPDH with a compound under conditions which allow oligomerization of GAPDH to occur; and measuring the ability of the compound to modulate oligomerization of GAPDH as an indication of whether the compound is an oligomeric modulator of GAPDH.
    Type: Application
    Filed: April 16, 2003
    Publication date: May 6, 2004
    Inventors: William G. Tatton, Katherine Borden
  • Deprenyl compounds for treatment of glaucoma
    Publication number: 20030139456
    Abstract: Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
    Type: Application
    Filed: August 2, 2002
    Publication date: July 24, 2003
    Inventor: William G. Tatton
  • Method for treating multiple sclerosis
    Publication number: 20030078295
    Abstract: Methods for increasing oligodendrocyte survival are disclosed. The methods of the invention are useful for the treatment of Multiple Sclerosis.
    Type: Application
    Filed: July 26, 2002
    Publication date: April 24, 2003
    Inventors: L. Sai Latha Shankar, William G. Tatton, Nadine A. Tatton
  • Methods for increasing schwann cell survival
    Publication number: 20030004104
    Abstract: Methods for increasing Schwann cell survival are disclosed. The methods of the invention are useful for the treatment of conditions such as peripheral neuropathies, including diabetic neuropathies.
    Type: Application
    Filed: March 22, 2002
    Publication date: January 2, 2003
    Inventors: Nadine A. Tatton, William G. Tatton
  • Methods for treating multiple sclerosis
    Patent number: 6492427
    Abstract: Methods for increasing oligodendrocyte survival are disclosed. The methods of the invention are useful for the treatment of Multiple Sclerosis.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: December 10, 2002
    Inventors: L. Sai Latha Shankar, William G. Tatton, Nadine A. Tatton
  • DEPRENYL COMPOUNDS TO TREAT VIRAL INFECTIONS AND REDUCE TISSUE DAMAGE ASSOCIATED THEREWITH
    Publication number: 20020137786
    Abstract: Methods for treating viral infections are disclosed. The methods of the invention are useful for inhibiting viral infection in a subject and for preventing reducing tissue damage associated with viral infections. The method can include the step of administering to a subject in need thereof a therapeutically effective amount of a deprenyl compound, such that treatment of a viral infection occurs.
    Type: Application
    Filed: February 11, 1999
    Publication date: September 26, 2002
    Inventors: WILLIAM G. TATTON, KATHERINE L. B. BORDEN, MARIA SALVATO
  • Deprenyl compounds for treatment of glaucoma
    Patent number: 6455590
    Abstract: Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: September 24, 2002
    Assignee: University of Toronto Innovations.Foundation
    Inventor: William G. Tatton
  • Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
    Publication number: 20020132829
    Abstract: The present invention relates to the use of deprenyl compounds to rescue damaged nerve cells in a patient and to kits containing deprenyl compounds useful for rescuing damaged nerve cells in a patient.
    Type: Application
    Filed: September 17, 2001
    Publication date: September 19, 2002
    Inventors: William G. Tatton, Carol E. Greenwood
  • Methods for increasing schwann cell survival
    Patent number: 6417160
    Abstract: Methods for increasing Schwann cell survival are disclosed. The methods of the invention are useful for the treatment of conditions such as peripheral neuropathies, including diabetic neuropathies.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: July 9, 2002
    Inventors: Nadine A. Tatton, William G. Tatton
  • METHODS FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20020022661
    Abstract: Methods for increasing oligodendrocyte survival are disclosed. The methods of the invention are useful for the treatment of Multiple Sclerosis.
    Type: Application
    Filed: October 8, 1999
    Publication date: February 21, 2002
    Inventors: SAI LATHA SHANKAR, WILLIAM G. TATTON, NADINE A. TATTON
  • Deprenyl compounds for treatment of glaucoma
    Patent number: 5981598
    Abstract: Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: November 9, 1999
    Assignee: The University of Toronto Innovations Foundation
    Inventor: William G. Tatton
  • Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
    Patent number: 5844003
    Abstract: The present invention relates to the use of deprenyl compounds to rescue damaged nerve cells in a patient and to kits containing deprenyl compounds useful for rescuing damaged nerve cells in a patient.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: December 1, 1998
    Assignee: Innovations Foundation
    Inventors: William G. Tatton, Carol E. Greenwood
  • Deprenyl compounds for treatment of glaucoma
    Patent number: 5783606
    Abstract: Methods and kits for treatment of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: July 21, 1998
    Assignee: The University of Toronto Innovations Foundation
    Inventor: William G. Tatton
  • Use of deprenyl to rescue damaged nerve cells
    Patent number: 5767164
    Abstract: The present invention relates to the use of deprenyl or derivatives or analogues of deprenyl to rescue damaged nerve cells in an animal; to pharmaceutical compositions containing deprenyl adapted for such use; and, to methods for the treatment of disorders of the nervous system by rescuing damaged nerve cells.
    Type: Grant
    Filed: January 18, 1995
    Date of Patent: June 16, 1998
    Assignee: Innovations Foundation
    Inventors: William G. Tatton, Carol E. Greenwood
  • Use of deprenyl to rescue damaged nerve cells
    Patent number: 5444095
    Abstract: The present invention relates to the use of deprenyl or derivatives or analogues of deprenyl to rescue damaged nerve cells in an animal; to pharmaceutical compositions containing deprenyl adapted for such use; and, to methods for the treatment of disorders of the nervous system by rescuing damaged nerve cells.
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: August 22, 1995
    Assignee: University of Toronto, Innovations Foundation
    Inventors: William G. Tatton, Carol E. Greenwood